Formulation and Drug Delivery

Lonza Expands HPAPI Capacity

June 17, 2019

Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.

2019 Michelson Prize Winners Announced

June 14, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The Michelson Medical Research Foundation and the Human Vaccines Project have awarded three young scientists $150,000 for their novel approaches toward human immune system research.

Biogen Completes $800-Million Acquisition of Nightstar Therapeutics

June 07, 2019

The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.

Consultation Opens on EMA’s Draft Guidelines on Drug-Device Combination Products

June 06, 2019

EMA has opened a three-month consultation on its draft guidelines on the quality of requirements for drug-device combination products.

European Private Equity Group Acquires UK Pharma Generics Firm

June 06, 2019

European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.

Enabling Technologies Advance Poorly Soluble Highly Potent APIs

June 02, 2019

Excipients and new processing techniques can make a real difference in the development of highly potent therapies.

Looking Beyond the Solubility Horizon

June 02, 2019

Exploration of various formulation techniques is vital to provide effective delivery of poorly soluble drugs.

Enhancing Bioavailability with Hot-Melt Extrusion

June 02, 2019

Discussing the advantages, limitations, and recent advances of HME with experts from AbbVie.

Considering Connected Inhalation Drug Delivery

June 02, 2019

A connected MDI may encourage compliance and aid proper technique.

Putting Drug Delivery into Patients’ Hands

June 02, 2019

Wearable and smart devices allow user-friendly subcutaneous drug delivery.